John Mariano

John Mariano is an accomplished technology leader with extensive experience in artificial intelligence, data, and engineering across multiple industries. Currently serving as Head of Artificial Intelligence, Data and Engineering at Alnylam Pharmaceuticals, John focuses on leveraging technology to enhance RNAi therapeutics. Previous roles include Senior Vice President at Fidelity Investments, where responsibilities encompassed data and platform engineering, as well as serving as Chief Technology Officer at Fidelity Labs. John co-founded Saifr.ai and held pivotal positions at Fidelity Investments, Microsoft, and the Royal Bank of Scotland, amassing expertise in software development, data analytics, and IT infrastructure. John’s academic background includes education from the Massachusetts Institute of Technology, Case Western Reserve University, Stanford University School of Engineering, Boston University, and Western New England University.